|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression multiple interactions |
ISO |
Anisomycin results in increased expression of ABCC3 mRNA SB 203580 inhibits the reaction [Anisomycin results in increased expression of ABCC3 mRNA] |
CTD |
PMID:27507784 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
increases expression |
ISO |
Anisomycin results in increased expression of AGER protein |
CTD |
PMID:33075463 |
|
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Ago2 |
argonaute RISC catalytic component 2 |
increases phosphorylation |
ISO |
Anisomycin results in increased phosphorylation of AGO2 protein |
CTD |
PMID:18476811 |
|
NCBI chr 7:105,018,202...105,105,118
Ensembl chr 7:105,029,120...105,104,974
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions decreases expression |
ISO |
Anisomycin promotes the reaction [Tetrachlorodibenzodioxin results in increased degradation of and results in decreased expression of AHR protein] Anisomycin results in decreased expression of AHR protein |
CTD |
PMID:15385644 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Arc |
activity-regulated cytoskeleton-associated protein |
decreases expression |
ISO |
anisomycin decreases expression of Arc protein in dorsal striatum |
RGD |
PMID:27567310 |
RGD:401901591 |
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
|
|
G |
Atf1 |
activating transcription factor 1 |
increases phosphorylation multiple interactions |
ISO |
Anisomycin results in increased phosphorylation of ATF1 protein [SB 203580 co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] inhibits the reaction [Anisomycin results in increased phosphorylation of ATF1 protein]; SB 203580 inhibits the reaction [Anisomycin results in increased phosphorylation of ATF1 protein] |
CTD |
PMID:12660819 |
|
NCBI chr 7:131,361,962...131,404,677
Ensembl chr 7:131,362,450...131,404,670
|
|
G |
Atf2 |
activating transcription factor 2 |
increases phosphorylation multiple interactions |
ISO |
Anisomycin results in increased phosphorylation of ATF2 protein pyrazolanthrone inhibits the reaction [Anisomycin results in increased phosphorylation of ATF2 protein]; SB 203580 inhibits the reaction [Anisomycin results in increased phosphorylation of ATF2 protein] |
CTD |
PMID:12663670 PMID:28975372 |
|
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Atf3 |
activating transcription factor 3 |
multiple interactions increases expression |
ISO |
[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [Anisomycin results in increased expression of ATF3 mRNA] |
CTD |
PMID:19101521 PMID:22003189 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atg13 |
autophagy related 13 |
decreases expression |
ISO |
Anisomycin results in decreased expression of ATG13 protein |
CTD |
PMID:27629431 |
|
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
|
|
G |
Atg4b |
autophagy related 4B, cysteine peptidase |
decreases expression |
ISO |
Anisomycin results in decreased expression of ATG4B protein |
CTD |
PMID:27629431 |
|
NCBI chr 9:94,282,417...94,314,109
Ensembl chr 9:94,282,509...94,314,103
|
|
G |
Bach2 |
BTB domain and CNC homolog 2 |
increases expression |
ISO |
Anisomycin results in increased expression of BACH2 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr 5:46,632,338...46,982,676
Ensembl chr 5:46,638,317...46,977,877
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
Anisomycin promotes the reaction [triethylene glycol dimethacrylate results in increased expression of BAX protein] |
CTD |
PMID:33684387 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP |
[Colistin co-treated with Anisomycin] results in increased phosphorylation of BCL2 protein |
CTD |
PMID:28842171 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
EXP |
Anisomycin promotes the reaction [Colistin results in increased expression of BECN1 protein] |
CTD |
PMID:28842171 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions |
ISO |
Anisomycin results in increased cleavage of and results in increased activity of BID protein |
CTD |
PMID:18241849 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
Anisomycin promotes the reaction [(+)-JQ1 compound results in decreased expression of BIRC5 protein] |
CTD |
PMID:23872705 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression |
ISO EXP |
Anisomycin promotes the reaction [Indomethacin results in increased activity of CASP3 protein]; Anisomycin results in increased cleavage of and results in increased activity of CASP3 protein [Colistin co-treated with Anisomycin] results in increased cleavage of CASP3 protein; Anisomycin inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]] Anisomycin results in increased expression of CASP3 protein modified form Anisomycin promotes the reaction [triethylene glycol dimethacrylate results in increased cleavage of CASP3 protein] |
CTD |
PMID:17341418 PMID:18241849 PMID:28842171 PMID:29944914 PMID:33684387 PMID:34767868 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp6 |
caspase 6 |
multiple interactions |
ISO |
Anisomycin promotes the reaction [Indomethacin results in increased activity of CASP6 protein] |
CTD |
PMID:17341418 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
Anisomycin results in increased activity of CASP8 protein |
CTD |
PMID:18241849 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO EXP |
Anisomycin promotes the reaction [Indomethacin results in increased activity of CASP9 protein] Anisomycin inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP9 protein]] |
CTD |
PMID:17341418 PMID:34767868 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cav1 |
caveolin 1 |
multiple interactions increases phosphorylation |
ISO |
wogonin inhibits the reaction [Anisomycin results in increased phosphorylation of CAV1 protein] |
CTD |
PMID:23246481 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
ISO |
Anisomycin results in decreased expression of CCL2 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
decreases expression |
ISO |
Anisomycin results in decreased expression of CCL4 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
decreases expression |
ISO |
Anisomycin results in decreased expression of CCL5 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
increases expression |
ISO |
Anisomycin results in increased expression of CD55 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
|
|
G |
Cd69 |
Cd69 molecule |
increases expression |
ISO |
Anisomycin results in increased expression of CD69 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
increases phosphorylation multiple interactions |
ISO |
Anisomycin results in increased phosphorylation of CREB1 protein SB 203580 inhibits the reaction [Anisomycin results in increased phosphorylation of CREB1 protein] |
CTD |
PMID:12660819 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crebbp |
CREB binding protein |
increases expression |
ISO |
Anisomycin results in increased expression of CREBBP mRNA |
CTD |
PMID:24247028 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Cs |
citrate synthase |
multiple interactions |
ISO |
Anisomycin affects the reaction [triethylene glycol dimethacrylate affects the activity of CS protein] |
CTD |
PMID:33684387 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions increases expression |
ISO |
[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [Anisomycin results in increased expression of CXCL1 mRNA] |
CTD |
PMID:22003189 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression multiple interactions |
ISO |
Anisomycin results in increased expression of CXCL1 mRNA [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [Anisomycin results in increased expression of CXCL1 mRNA] |
CTD |
PMID:22003189 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
ISO |
Anisomycin results in increased expression of CYP1A1 mRNA [Anisomycin co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP1A1 mRNA |
CTD |
PMID:15385644 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
Anisomycin inhibits the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] |
CTD |
PMID:16038797 |
|
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
multiple interactions |
ISO |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [[Anisomycin co-treated with NR1I3 protein] results in increased expression of CYP2A7 mRNA]; [Anisomycin co-treated with NR1I3 protein] results in increased expression of CYP2A7 mRNA |
CTD |
PMID:23539296 |
|
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Anisomycin co-treated with NR1I3 protein] results in increased expression of CYP2B6 mRNA Anisomycin promotes the reaction [[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with NR1I3 protein] results in increased expression of CYP2B6 mRNA] |
CTD |
PMID:23539296 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Anisomycin results in increased expression of DDIT3 mRNA |
CTD |
PMID:18241849 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
decreases expression |
ISO |
Anisomycin results in decreased expression of DUSP6 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dusp8 |
dual specificity phosphatase 8 |
multiple interactions |
ISO |
DUSP8 protein inhibits the reaction [Anisomycin results in increased phosphorylation of JUN protein]; DUSP8 protein inhibits the reaction [Anisomycin results in increased phosphorylation of NR3C1 protein] |
CTD |
PMID:32780722 |
|
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions increases expression |
ISO |
SB 203580 inhibits the reaction [Anisomycin results in increased expression of EGR1 mRNA] |
CTD |
PMID:9671412 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
increases phosphorylation multiple interactions |
ISO |
Anisomycin results in increased phosphorylation of EIF4E protein SB 203580 inhibits the reaction [Anisomycin results in increased phosphorylation of EIF4E protein] |
CTD |
PMID:9545260 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
increases phosphorylation multiple interactions |
ISO |
Anisomycin results in increased phosphorylation of ELK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Anisomycin results in increased phosphorylation of ELK1 protein]; pyrazolanthrone inhibits the reaction [Anisomycin results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:12660819 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Evi2a |
ecotropic viral integration site 2A |
increases expression |
ISO |
Anisomycin results in increased expression of EVI2A mRNA |
CTD |
PMID:24247028 |
|
NCBI chr10:64,485,760...64,489,660
Ensembl chr10:64,485,200...64,489,843
|
|
G |
Fas |
Fas cell surface death receptor |
increases localization |
ISO |
Anisomycin results in increased localization of FAS protein |
CTD |
PMID:18241849 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Anisomycin results in increased expression of FOS mRNA |
CTD |
PMID:12660819 PMID:18241849 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Anisomycin results in increased expression of FOSB mRNA |
CTD |
PMID:18241849 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
multiple interactions |
ISO |
Anisomycin inhibits the reaction [GHRL protein inhibits the reaction [Uranium results in decreased expression of and results in decreased secretion of TNFRSF11B protein]]; Anisomycin inhibits the reaction [GHRL protein inhibits the reaction [Uranium results in increased expression of and results in increased secretion of TNFSF11 protein]] |
CTD |
PMID:29477364 |
|
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
|
|
G |
Hoxa1 |
homeobox A1 |
multiple interactions |
ISO |
Anisomycin promotes the reaction [Tretinoin results in increased expression of HOXA1 mRNA] |
CTD |
PMID:16038797 |
|
NCBI chr 4:81,255,814...81,258,587
Ensembl chr 4:81,255,883...81,258,504
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression |
ISO |
Anisomycin results in decreased expression of HSPA5 mRNA; Anisomycin results in decreased expression of HSPA5 protein |
CTD |
PMID:25324550 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
multiple interactions |
EXP |
Anisomycin inhibits the reaction [Cocaine results in increased expression of HSPA9 protein] |
CTD |
PMID:12422371 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
Anisomycin inhibits the reaction [TNF protein results in increased expression of and affects the localization of ICAM1 protein] |
CTD |
PMID:21448188 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
Anisomycin promotes the reaction [IGF1 protein results in increased phosphorylation of JUN protein] |
CTD |
PMID:11278392 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions |
ISO |
Anisomycin results in increased expression of IL1B protein Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased expression of IL1B protein]] |
CTD |
PMID:15019843 PMID:36928891 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased expression of IL6 protein]] |
CTD |
PMID:36928891 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
decreases expression |
ISO |
Anisomycin results in decreased expression of IL6R protein modified form |
CTD |
PMID:20116850 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression increases phosphorylation |
ISO EXP |
Anisomycin promotes the reaction [IGF1 protein results in increased phosphorylation of JUN protein]; DUSP8 protein inhibits the reaction [Anisomycin results in increased phosphorylation of JUN protein] Anisomycin results in increased expression of JUN mRNA |
CTD |
PMID:9751194 PMID:11278392 PMID:15019843 PMID:18241849 PMID:21815634 PMID:32780722 More...
|
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Anisomycin results in increased expression of JUND mRNA |
CTD |
PMID:18241849 |
|
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
Anisomycin results in increased expression of MAFF mRNA |
CTD |
PMID:24247028 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Map3k20 |
mitogen-activated protein kinase kinase kinase 20 |
multiple interactions |
ISO |
MAP3K20 protein promotes the reaction [Anisomycin results in increased phosphorylation of and results in increased activity of MAPK8 protein]; quinoline analog inhibits the reaction [MAP3K20 protein promotes the reaction [Anisomycin results in increased phosphorylation of and results in increased activity of MAPK8 protein]] |
CTD |
PMID:15737997 |
|
NCBI chr 3:57,130,539...57,289,943
Ensembl chr 3:57,130,551...57,289,626
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation increases activity increases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Anisomycin results in increased phosphorylation of MAPK1 protein]; Anisomycin promotes the reaction [thymoquinone results in increased phosphorylation of MAPK1 protein] 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Anisomycin results in increased phosphorylation of MAPK1 protein]; SB 203580 promotes the reaction [Anisomycin results in increased phosphorylation of MAPK1 protein] Anisomycin results in increased activity of MAPK1 protein Anisomycin results in increased expression of MAPK1 protein modified form |
CTD |
PMID:9671412 PMID:11551972 PMID:12660819 PMID:15772366 PMID:25233930 PMID:34173702 More...
|
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk10 |
mitogen activated protein kinase 10 |
multiple interactions increases activity |
ISO |
Dicumarol inhibits the reaction [Anisomycin results in increased activity of MAPK10 protein] |
CTD |
PMID:10531305 |
|
NCBI chr14:6,497,662...6,790,109
Ensembl chr14:6,497,707...6,786,201
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions increases phosphorylation |
ISO EXP |
Anisomycin results in increased phosphorylation of and results in increased activity of MAPK14 protein MAPK14 protein affects the reaction [Anisomycin results in increased activity of MAPKAPK2 protein] Anisomycin results in increased phosphorylation of MAPK14 protein |
CTD |
PMID:10704466 PMID:15961565 PMID:16038797 PMID:16364386 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation increases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Anisomycin results in increased phosphorylation of MAPK3 protein]; Anisomycin promotes the reaction [thymoquinone results in increased phosphorylation of MAPK3 protein] 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Anisomycin results in increased phosphorylation of MAPK3 protein] Anisomycin results in increased expression of MAPK3 protein modified form |
CTD |
PMID:12660819 PMID:15772366 PMID:25233930 PMID:34173702 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation multiple interactions increases activity |
ISO EXP |
Anisomycin results in increased phosphorylation of MAPK8 protein 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Anisomycin results in increased phosphorylation of MAPK8 protein] Anisomycin results in increased phosphorylation of and results in increased activity of MAPK8 protein Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased phosphorylation of MAPK8 protein]]; Anisomycin results in increased phosphorylation of and results in increased activity of MAPK8 protein; MAP3K20 protein promotes the reaction [Anisomycin results in increased phosphorylation of and results in increased activity of MAPK8 protein]; quinoline analog inhibits the reaction [MAP3K20 protein promotes the reaction [Anisomycin results in increased phosphorylation of and results in increased activity of MAPK8 protein]] Anisomycin results in increased activity of MAPK8 protein |
CTD |
PMID:12902192 PMID:12967334 PMID:15737997 PMID:15772366 PMID:15961565 PMID:16038797 PMID:18241849 PMID:33075463 PMID:36928891 More...
|
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions increases phosphorylation |
ISO |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Anisomycin results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:12967334 PMID:15772366 PMID:16038797 PMID:33075463 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mapkapk2 |
MAPK activated protein kinase 2 |
increases activity multiple interactions |
ISO |
Anisomycin results in increased activity of MAPKAPK2 protein MAPK14 protein affects the reaction [Anisomycin results in increased activity of MAPKAPK2 protein] |
CTD |
PMID:10704466 |
|
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
|
|
G |
Mknk1 |
MAPK interacting serine/threonine kinase 1 |
increases activity multiple interactions |
ISO |
Anisomycin results in increased activity of MKNK1 protein SB 203580 inhibits the reaction [Anisomycin results in increased activity of MKNK1 protein] |
CTD |
PMID:9545260 |
|
NCBI chr 5:129,318,128...129,357,641
Ensembl chr 5:129,318,170...129,357,639
|
|
G |
Mrps30 |
mitochondrial ribosomal protein S30 |
increases expression |
ISO |
Anisomycin results in increased expression of MRPS30 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr 2:50,456,253...50,463,128
Ensembl chr 2:50,456,255...50,463,105
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
ISO |
Anisomycin results in increased expression of MYC mRNA |
CTD |
PMID:24247028 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nefh |
neurofilament heavy chain |
decreases degradation |
EXP |
Anisomycin results in decreased degradation of NEFH mRNA |
CTD |
PMID:1280263 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Nefl |
neurofilament light chain |
decreases degradation |
EXP |
Anisomycin results in decreased degradation of NEFL mRNA |
CTD |
PMID:1280263 |
|
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Nefm |
neurofilament medium chain |
decreases degradation |
EXP |
Anisomycin results in decreased degradation of NEFM mRNA |
CTD |
PMID:1280263 |
|
NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
multiple interactions |
ISO |
[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [Anisomycin results in increased expression of ATF3 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [Anisomycin results in increased expression of CXCL1 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [Anisomycin results in increased expression of CXCL8 mRNA] |
CTD |
PMID:22003189 |
|
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
ISO |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [[Anisomycin co-treated with NR1I3 protein] results in increased expression of CYP2A7 mRNA]; [Anisomycin co-treated with 1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with NR1I3 protein] results in increased expression of CYP2C9 mRNA; [Anisomycin co-treated with NR1I3 protein] results in increased expression of CYP2A7 mRNA; Anisomycin promotes the reaction [[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with NR1I3 protein] results in increased expression of CYP2B6 mRNA] [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Anisomycin co-treated with NR1I3 protein] results in increased expression of CYP2B6 mRNA |
CTD |
PMID:23539296 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
increases phosphorylation multiple interactions |
ISO |
Anisomycin results in increased phosphorylation of NR3C1 protein DUSP8 protein inhibits the reaction [Anisomycin results in increased phosphorylation of NR3C1 protein] |
CTD |
PMID:32780722 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
[Colistin co-treated with Anisomycin] results in increased cleavage of PARP1 protein; Anisomycin inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of PARP1 protein]] |
CTD |
PMID:28842171 PMID:34767868 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
increases expression |
ISO |
Anisomycin results in increased expression of PMAIP1 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Postn |
periostin |
increases expression |
EXP |
Anisomycin results in increased expression of POSTN mRNA |
CTD |
PMID:15121739 |
|
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
|
|
G |
Ptpn5 |
protein tyrosine phosphatase, non-receptor type 5 |
multiple interactions |
EXP |
Anisomycin inhibits the reaction [Isoproterenol results in increased expression of PTPN5 protein] |
CTD |
PMID:17623046 |
|
NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:97,620,642...97,679,882
|
|
G |
Rarb |
retinoic acid receptor, beta |
multiple interactions |
ISO |
Anisomycin promotes the reaction [Tretinoin results in increased expression of RARB mRNA] |
CTD |
PMID:16038797 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Ret |
ret proto-oncogene |
decreases expression |
EXP |
Anisomycin results in decreased expression of RET protein |
CTD |
PMID:17555550 |
|
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
|
|
G |
Rhoh |
ras homolog family member H |
increases expression |
ISO |
Anisomycin results in increased expression of RHOH mRNA |
CTD |
PMID:24247028 |
|
NCBI chr14:42,341,135...42,371,971
Ensembl chr14:42,337,751...42,386,369
|
|
G |
Rora |
RAR-related orphan receptor A |
increases expression |
ISO |
Anisomycin results in increased expression of RORA mRNA |
CTD |
PMID:24247028 |
|
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
|
|
G |
Rxra |
retinoid X receptor alpha |
increases phosphorylation multiple interactions |
ISO |
Anisomycin results in increased phosphorylation of RXRA protein pyrazolanthrone inhibits the reaction [Anisomycin results in increased phosphorylation of RXRA protein] |
CTD |
PMID:16038797 PMID:16184197 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
EXP ISO |
Anisomycin promotes the reaction [Colistin results in increased degradation of SQSTM1 protein] Anisomycin promotes the reaction [triethylene glycol dimethacrylate results in increased expression of SQSTM1 protein] |
CTD |
PMID:28842171 PMID:33684387 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srf |
serum response factor |
increases phosphorylation multiple interactions |
ISO |
Anisomycin results in increased phosphorylation of SRF protein SB 203580 inhibits the reaction [Anisomycin results in increased phosphorylation of SRF protein] |
CTD |
PMID:12660819 |
|
NCBI chr 9:14,426,453...14,435,734
Ensembl chr 9:14,426,472...14,435,733
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions |
ISO |
Anisomycin promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; Anisomycin results in increased expression of and results in increased stability of STAR mRNA |
CTD |
PMID:15713539 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tnf |
tumor necrosis factor |
increases expression multiple interactions |
ISO |
Anisomycin results in increased expression of TNF mRNA Anisomycin inhibits the reaction [rutecarpine inhibits the reaction [Glucose results in increased expression of TNF protein]]; Anisomycin inhibits the reaction [TNF protein results in increased expression of and affects the localization of ICAM1 protein] |
CTD |
PMID:18241849 PMID:21448188 PMID:36928891 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
multiple interactions |
ISO |
Anisomycin inhibits the reaction [GHRL protein inhibits the reaction [Uranium results in decreased expression of and results in decreased secretion of TNFRSF11B protein]] |
CTD |
PMID:29477364 |
|
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions |
ISO |
Anisomycin inhibits the reaction [GHRL protein inhibits the reaction [Uranium results in increased expression of and results in increased secretion of TNFSF11 protein]] |
CTD |
PMID:29477364 |
|
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Tnfsf9 |
TNF superfamily member 9 |
increases expression decreases expression |
ISO |
Anisomycin results in increased expression of TNFSF9 mRNA Anisomycin results in decreased expression of TNFSF9 mRNA |
CTD |
PMID:18241849 PMID:24247028 |
|
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
EXP |
Anisomycin promotes the reaction [Colistin results in increased expression of TP53 protein] |
CTD |
PMID:28842171 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Txnip |
thioredoxin interacting protein |
increases expression |
ISO |
Anisomycin results in increased expression of TXNIP mRNA |
CTD |
PMID:10843682 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Ulk1 |
unc-51 like autophagy activating kinase 1 |
decreases expression |
ISO |
Anisomycin results in decreased expression of ULK1 protein |
CTD |
PMID:27629431 |
|
NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
|
|
G |
Usp30 |
ubiquitin specific peptidase 30 |
increases expression |
ISO |
Anisomycin results in increased expression of USP30 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr12:42,501,345...42,555,311
Ensembl chr12:42,501,348...42,555,616
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
Anisomycin results in decreased expression of VEGFA protein |
CTD |
PMID:20116850 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Xbp1 |
X-box binding protein 1 |
decreases splicing |
ISO |
Anisomycin results in decreased splicing of XBP1 mRNA |
CTD |
PMID:25324550 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|